Explore more publications!
STEM Wire Oklahoma
Got News to Share?

STEM Wire Oklahoma: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Wire Oklahoma.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on April 14, 2026

기업의 약 80%는 “데이터 접근성 문제로 AI 활용에 제약”… Cloudera 보고서
Apr. 14, 2026

기업의 약 80%는 “데이터 접근성 문제로 AI 활용에 제약”… Cloudera 보고서

Indeterminate GlobeNewswire
Cloudera 最新报告发现：近 80% 的企业表示 AI 发展受限于数据访问难题
Apr. 14, 2026

Cloudera 最新报告发现：近 80% 的企业表示 AI 发展受限于数据访问难题

Indeterminate GlobeNewswire
クラウデラの最新レポートによると、企業の80%近くが、AIの導入がデータアクセスの課題によって阻害されていると回答
Apr. 14, 2026

クラウデラの最新レポートによると、企業の80%近くが、AIの導入がデータアクセスの課題によって阻害されていると回答

Indeterminate GlobeNewswire
Hampir 80% Perusahaan Menyatakan AI Terhalang oleh Cabaran Akses Data, Laporan Baharu Cloudera Mendedahkan
Apr. 14, 2026

Hampir 80% Perusahaan Menyatakan AI Terhalang oleh Cabaran Akses Data, Laporan Baharu Cloudera Mendedahkan

Indeterminate GlobeNewswire
Cloudera 最新報告發現，近 80% 企業認為數據存取的困難阻礙了人工智能的發展
Apr. 14, 2026

Cloudera 最新報告發現，近 80% 企業認為數據存取的困難阻礙了人工智能的發展

Indeterminate GlobeNewswire
Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma
Apr. 14, 2026

Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma

Indeterminate GlobeNewswire
ZenaTech cierra la adquisición de NOW Solutions Inc., amplía su división SaaS empresarial con clientes gubernamentales y del sector público y fortalece el crecimiento de los ingresos recurrentes
Apr. 14, 2026

ZenaTech cierra la adquisición de NOW Solutions Inc., amplía su división SaaS empresarial con clientes gubernamentales y del sector público y fortalece el crecimiento de los ingresos recurrentes

Indeterminate GlobeNewswire
Akaysha Energy Begins Construction on Elaine BESS, Supported by InEight Document
Apr. 14, 2026

Akaysha Energy Begins Construction on Elaine BESS, Supported by InEight Document

Indeterminate GlobeNewswire
Broadcom Announces Extended Partnership with Meta to Deploy Technology to Support Multi-Gigawatts of Meta’s Custom Silicon, MTIA
Apr. 14, 2026

Broadcom Announces Extended Partnership with Meta to Deploy Technology to Support Multi-Gigawatts of Meta’s Custom Silicon, MTIA

Indeterminate GlobeNewswire
AI-powered Social News Network Pulse Launches to Deliver High-Signal Insights for Professionals
Apr. 14, 2026

AI-powered Social News Network Pulse Launches to Deliver High-Signal Insights for Professionals

Indeterminate GlobeNewswire
Stride Announces Date for Third Quarter Fiscal Year 2026 Earnings Call
Apr. 14, 2026

Stride Announces Date for Third Quarter Fiscal Year 2026 Earnings Call

Indeterminate GlobeNewswire
Dumb Money Announces Public Launch as Retail Investors Reclaim the Market Narrative
Apr. 14, 2026

Dumb Money Announces Public Launch as Retail Investors Reclaim the Market Narrative

Indeterminate GlobeNewswire
Parker to Announce Fiscal 2026 Third Quarter Earnings on April 30; Conference Call and Webcast Scheduled for 11 a.m. Eastern
Apr. 14, 2026

Parker to Announce Fiscal 2026 Third Quarter Earnings on April 30; Conference Call and Webcast Scheduled for 11 a.m. Eastern

Indeterminate GlobeNewswire
Mercury Systems to Report Third Quarter Fiscal Year 2026 Financial Results on May 5, 2026
Apr. 14, 2026

Mercury Systems to Report Third Quarter Fiscal Year 2026 Financial Results on May 5, 2026

Indeterminate GlobeNewswire
Aligos Therapeutics Announces First Interim Analysis Results from the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium in Participants with Chronic Hepatitis B Virus Infection and Grant of FDA Fast Track Designation
Apr. 14, 2026

Aligos Therapeutics Announces First Interim Analysis Results from the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium in Participants with Chronic Hepatitis B Virus Infection and Grant of FDA Fast Track Designation

Indeterminate GlobeNewswire
Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel
Apr. 14, 2026

Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel

Indeterminate GlobeNewswire
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Apr. 14, 2026

Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
EverQuote to Announce First Quarter 2026 Financial Results on May 4, 2026
Apr. 14, 2026

EverQuote to Announce First Quarter 2026 Financial Results on May 4, 2026

Indeterminate GlobeNewswire
Galera Therapeutics and Obsidian Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement
Apr. 14, 2026

Galera Therapeutics and Obsidian Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement

Indeterminate GlobeNewswire
As AI Agents Get Involved in Financial Data Sharing, Leading Standards Body Launches Initiative to Stay Ahead
Apr. 14, 2026

As AI Agents Get Involved in Financial Data Sharing, Leading Standards Body Launches Initiative to Stay Ahead

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions